Tempest Therapeutics, Inc. (TPST)
0.89
-0.02
(-2.08%)
USD |
NASDAQ |
Sep 10, 11:11
Tempest Therapeutics Total Assets (Quarterly) : 9.633M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.633M |
| March 31, 2026 | 10.75M |
| December 31, 2025 | 19.13M |
| September 30, 2025 | 17.13M |
| June 30, 2025 | 24.48M |
| March 31, 2025 | 32.16M |
| December 31, 2024 | 44.02M |
| September 30, 2024 | 33.84M |
| June 30, 2024 | 42.17M |
| March 31, 2024 | 44.38M |
| December 31, 2023 | 51.60M |
| September 30, 2023 | 23.99M |
| June 30, 2023 | 30.74M |
| March 31, 2023 | 37.33M |
| December 31, 2022 | 46.09M |
| September 30, 2022 | 63.17M |
| June 30, 2022 | 71.35M |
| March 31, 2022 | 66.95M |
| December 31, 2021 | 73.24M |
| September 30, 2021 | 67.14M |
| June 30, 2021 | 75.50M |
| March 31, 2021 | 31.71M |
| December 31, 2020 | 22.86M |
| September 30, 2020 | 48.84M |
| June 30, 2020 | 57.13M |
| Date | Value |
|---|---|
| March 31, 2020 | 68.04M |
| December 31, 2019 | 74.97M |
| September 30, 2019 | 58.48M |
| June 30, 2019 | 68.32M |
| March 31, 2019 | 74.30M |
| December 31, 2018 | |
| September 30, 2018 | 49.23M |
| June 30, 2018 | 55.53M |
| March 31, 2018 | 63.03M |
| December 31, 2017 | 72.85M |
| September 30, 2017 | 82.02M |
| June 30, 2017 | 93.88M |
| March 31, 2017 | 106.32M |
| December 31, 2016 | 122.54M |
| September 30, 2016 | 142.40M |
| June 30, 2016 | 158.72M |
| March 31, 2016 | 122.06M |
| December 31, 2015 | 138.61M |
| September 30, 2015 | 152.81M |
| June 30, 2015 | 164.45M |
| March 31, 2015 | 175.78M |
| December 31, 2014 | 65.57M |
| September 30, 2014 | 77.50M |
| June 30, 2014 | 85.83M |
| March 31, 2014 | 92.76M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.72M |
| Shareholders Equity (Quarterly) | -1.09M |
| Debt to Equity Ratio | -6.936 |
| Current Ratio | 0.3813 |
| Net Debt Paydown Yield | 6.25% |